Boston Scientific Announces Canadian Approval and Launch of PROMUS Element ...
Canada NewsWire (press release)
NATICK, Mass., April 25, 2012 /CNW/ - Boston Scientific Corporation (NYSE: BSX) announces Health Canada approval and market launch of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System in Canada.
Platinum coronary stent gets Canadian approval
Boston Announces Canadian Approval, Launch Of PROMUS Element Plus Stent System